EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Pretreatment Neutrophil‐to‐Lymphocyte Ratio ( NLR ) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study

Raisa Chowdhury iD, Karim Botros iD, Keith Richardson, Alex M Mlynarek, Nader Sadeghi, Michael P Hier, Sabrina Wurzba, Khashayar Esfahani, Nathaniel Bouganim, Khalil Sultanem, George Shenouda, Christina Tsien und 1 weitere

Head & Neck · 2025

DOI: 10.1002/hed.28212 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Head & Neck, 2025. Verfasst von Raisa Chowdhury und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Neutrophils, Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pretreatment neutrophil to lymphocyte ratio (NLR) is a negative prognostic marker for survival in head and neck cancer (HNC). Its association with treatment toxicity and intolerance in patients undergoing curative‐intent surgery is unknown.

Methods

Ambispective study of patients with operable stage II–IV, HPV‐negative HNC treated at two academic hospitals. Multiple logistic regression was performed to evaluate the association between pretreatment NLR and short‐term treatment outcomes including treatment toxicity and intolerance.

Results

Among 456 patients, 194 experienced treatment‐related toxicity, defined as grade ≥ 3 adverse events, and 200 exhibited treatment intolerance, defined as treatment discontinuation or delay due to poor tolerance. High pretreatment NLR was significantly associated with an increased risk of toxicity (OR 1.04; 95% CI: 1.00–1.09) and intolerance (OR 1.06; 95% CI: 1.01–1.12). Patients with an NLR < 2.5 had significantly lower odds of experiencing toxicity (OR 0.50; 95% CI: 0.26–0.96) and intolerance (OR 0.57; 95% CI: 0.33–0.99) after adjusting for multiple confounders.

Conclusions

Low pretreatment NLR was associated with reduced treatment toxicity and lower rates of intolerance in patients undergoing curative‐intent surgery for HNC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsNeutrophilsLymphocytesHumansMaleFemaleMiddle AgedAgedLymphocyte CountRetrospective StudiesCohort StudiesAdultPrognosisLogistic ModelsLeukocyte CountTreatment OutcomeNeoplasm Staging

Stichwörter der Autor:innen

head and neck cancerneutrophil‐to‐lymphocyte ratio (NLR)prognostic biomarkertreatment intolerancetreatment toxicity

Autor:innen und Institutionen

  • Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
  • Department of Otolaryngology-Head and Neck Surgery, McGill University, Montreal, Quebec, Canada.
  • Department of Medical Oncology, McGill University, Montreal, Quebec, Canada.
  • Department of Radiation Oncology, McGill University, Montreal, Quebec, Canada.
  • Center for clinical epidemiology, Lady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada.
  • Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

ORCID-Profile: Raisa Chowdhury, Karim Botros

Zitieren

APA

Chowdhury, R., Botros, K., Richardson, K., Mlynarek, A. M., Sadeghi, N., Hier, M. P., Wurzba, S., Esfahani, K., Bouganim, N., Sultanem, K., Shenouda, G., Tsien, C., & Mascarella, M. A. (2025). Pretreatment Neutrophil‐to‐Lymphocyte Ratio ( NLR ) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study. Head & Neck. https://doi.org/10.1002/hed.28212

Vancouver

Chowdhury R, Botros K, Richardson K, Mlynarek AM, Sadeghi N, Hier MP, et al. Pretreatment Neutrophil‐to‐Lymphocyte Ratio ( NLR ) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study. Head & Neck. 2025. doi:10.1002/hed.28212

BibTeX
@article{Chowdhury2025,
  author = {Chowdhury, Raisa and Botros, Karim and Richardson, Keith and Mlynarek, Alex M and Sadeghi, Nader and Hier, Michael P and Wurzba, Sabrina and Esfahani, Khashayar and Bouganim, Nathaniel and Sultanem, Khalil and Shenouda, George and Tsien, Christina and Mascarella, Marco A},
  title = {Pretreatment Neutrophil‐to‐Lymphocyte Ratio ( NLR ) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28212}
}
Kostenlos starten →